Solasia Pharma KK
TSE:4597
Solasia Pharma KK
Net Income
Solasia Pharma KK
Net Income Peer Comparison
Competitive Net Income Analysis
Latest Figures & CAGR of Competitors
Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Solasia Pharma KK
TSE:4597
|
Net Income
-¥1.2B
|
CAGR 3-Years
34%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Net Income
¥14.5B
|
CAGR 3-Years
91%
|
CAGR 5-Years
76%
|
CAGR 10-Years
N/A
|
|
PeptiDream Inc
TSE:4587
|
Net Income
¥4.4B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Net Income
¥2.9B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
3%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Net Income
¥147m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
S
|
StemRIM Inc
TSE:4599
|
Net Income
¥170.2m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Solasia Pharma KK's Net Income?
Net Income
-1.2B
JPY
Based on the financial report for Mar 31, 2024, Solasia Pharma KK's Net Income amounts to -1.2B JPY.
What is Solasia Pharma KK's Net Income growth rate?
Net Income CAGR 5Y
14%
Over the last year, the Net Income growth was 43%. The average annual Net Income growth rates for Solasia Pharma KK have been 34% over the past three years , 14% over the past five years .